The drug, Ibtrozi, will now vie for market share in an indication where multiple large pharmaceutical companies have already ...

President Trump's executive order seeking to tie U.S. drug prices to those abroad could impact future investment in Am ...

Takeda Pharmaceutical's booth at the fifth CIIE. [Photo/VCG] Acknowledging ... On Jan 2, Swiss pharmaceutical company Roche reached an agreement with Suzhou, Jiangsu province-based biopharmaceutical ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

It will grow to $13.84 billion in 2029 at a compound annual growth rate (CAGR) of 16.7%.” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services. By Michael Levenson 23andMe, the genetic ...

Roche reported top-line growth of 7% (6% constant currency) in the first quarter, stemming from 9% pharmaceuticals growth and flat diagnostics sales. Management maintained its outlook for mid ...

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs.The Basel-based company, whose array of ...

The investment plans include new R&D sites in four US states and creating more than 12,000 jobs, according to the Swiss pharmaceutical company. Swiss pharmaceuticals powerhouse Roche announced ...